Open AccessNivolumab in relapsed/refractory Hodgkin Lymphoma patients, single center experiences
Author(s) -
Ramazan Acar,
Murat Yıldırım
Publication year - 2020
Publication title -
medicine science
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2147-0634
DOI - 10.5455/medscience.2020.07.125
Subject(s) - nivolumab , medicine , refractory (planetary science) , lymphoma , progression free survival , immunotherapy , oncology , chemotherapy , hodgkin lymphoma , cancer , physics , astrobiology